Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Filters applied: . Clear all
Page 1
Is preoperative weight reduction of living-donor liver transplant recipients and donors harmful to postoperative outcomes?
Yoshiya S, Itoh S, Toshima T, Izumi T, Iseda N, Tsutsui Y, Toshida K, Nakayama Y, Ishikawa T, Tanaka Y, Ninomiya M, Yoshizumi T. Yoshiya S, et al. Among authors: ishikawa t. J Gastrointest Surg. 2024 Apr 15:S1091-255X(24)00411-6. doi: 10.1016/j.gassur.2024.04.010. Online ahead of print. J Gastrointest Surg. 2024. PMID: 38631611

RESULTS: Twenty-two recipients (10.1%) achieved WR (preoperative recipient WR [RWR] group), reducing their weight by 6.8% 6.0% within 2.2 1.4 months with a significant decrease in body mass index (BMI) (p < 0.0001). The RWR group showed no significant differences in short-t

…
RESULTS: Twenty-two recipients (10.1%) achieved WR (preoperative recipient WR [RWR] group), reducing their weight by 6.8% 6.0% within 2.2 1. …
Emerging measurements for tumor-infiltrating lymphocytes in breast cancer.
Wu R, Horimoto Y, Oshi M, Benesch MGK, Khoury T, Takabe K, Ishikawa T. Wu R, et al. Among authors: ishikawa t. Jpn J Clin Oncol. 2024 Mar 23:hyae033. doi: 10.1093/jjco/hyae033. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 38521965
Tumor-infiltrating lymphocytes are a general term for lymphocytes or immune cells infiltrating the tumor microenvironment. ...
Tumor-infiltrating lymphocytes are a general term for lymphocytes or immune cells infiltrating the tumor microenvironment. ...
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Rimini M, Stefanini B, Tada T, Suda G, Shimose S, Kudo M, Finkelmeier F, Yoo C, Presa J, Amadeo E, Genovesi V, De Grandis MC, Iavarone M, Marra F, Foschi F, Tamburini E, Rossari F, Vitiello F, Bartalini L, Soldà C, Tovoli F, Vivaldi C, Lonardi S, Silletta M, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Himmelsbach V, Montes M, Hiraoka A, Sho T, Niizeki T, Nishida N, Steup C, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Persano M, Camera S, Foti S, Aldrighetti L, Cascinu S, Casadei-Gardini A, Piscaglia F. Rimini M, et al. Among authors: ishikawa t. Liver Int. 2024 May;44(5):1108-1125. doi: 10.1111/liv.15885. Epub 2024 Mar 22. Liver Int. 2024. PMID: 38517286
INTRODUCTION: Overweight is a negative prognostic factor in the general population in the long term. However, the role of body mass index (BMI) in the short-mid term in advanced tumours is unclear. ...
INTRODUCTION: Overweight is a negative prognostic factor in the general population in the long term. However, the role of body mass i …
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.
Jang TY, Liang PC, Jun DW, Jung JH, Toyoda H, Wang CW, Yuen MF, Cheung KS, Yasuda S, Kim SE, Yoon EL, An J, Enomoto M, Kozuka R, Chuma M, Nozaki A, Ishikawa T, Watanabe T, Atsukawa M, Arai T, Hayama K, Ishigami M, Cho YK, Ogawa E, Kim HS, Shim JJ, Uojima H, Jeong SW, Ahn SB, Takaguchi K, Senoh T, Buti M, Vargas-Accarino I E, Abe H, Takahashi H, Inoue K, Yeh ML, Dai CY, Huang JF, Huang CF, Chuang WL, Nguyen MH, Yu ML. Jang TY, et al. Among authors: ishikawa t. J Gastroenterol Hepatol. 2024 Mar 13. doi: 10.1111/jgh.16537. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 38480009
After propensity score matching, no significant differences in all-cause, liver-related, or non-liver-related mortality were observed between the two groups. CONCLUSIONS: Long-term outcomes of all-cause mortality and liver-related and non-liver-related mortality did not di …
After propensity score matching, no significant differences in all-cause, liver-related, or non-liver-related mortality were observed betwee …
Impact of 1-year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis.
Sakurai E, Kamata M, Uchida H, Okada Y, Suzuki S, Takeshima R, Ito M, Watanabe A, Mizukawa I, Egawa S, Chijiwa C, Hiura A, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Tada Y. Sakurai E, et al. Among authors: ishikawa t. Exp Dermatol. 2024 Feb;33(2):e15022. doi: 10.1111/exd.15022. Exp Dermatol. 2024. PMID: 38414066
Recently, dupilumab was approved for AD, but its impact on work productivity in Japanese patients has not been reported. Furthermore, data on the effect of long-term treatment with dupilumab on work productivity are limited. We investigated the work productivity and activi …
Recently, dupilumab was approved for AD, but its impact on work productivity in Japanese patients has not been reported. Furthermore, data o …
Factors associated with the introduction of visiting-pharmacist services in older adults in Japan: A nested case-control study.
Taguchi R, Hamada S, Michihata N, Tsuchiya-Ito R, Kitamura S, Ishikawa T, Iwagami M. Taguchi R, et al. Among authors: ishikawa t. Geriatr Gerontol Int. 2024 Apr;24(4):344-351. doi: 10.1111/ggi.14838. Epub 2024 Feb 21. Geriatr Gerontol Int. 2024. PMID: 38379434
A maximum of four controls to each case patient were randomly selected on the basis of sex, age, health insurance systems, and month-year. Medical and long-term care service usage and patient condition were assessed using claims data from the index and preceding months, al …
A maximum of four controls to each case patient were randomly selected on the basis of sex, age, health insurance systems, and month-year. M …
Clinical Efficacy and Body Composition Changes with Sodium Glucose Cotransporter 2 Inhibitor/Glucagon-like Peptide-1 Antagonist Combination Therapy in Patients with Type 2 Diabetes Mellitus-associated Nonalcoholic Fatty Liver Disease.
Ishikawa T, Terai N, Sato R, Jimbo R, Kobayashi Y, Sato T, Iwanaga A, Sano T, Yokoyama J, Honma T. Ishikawa T, et al. Intern Med. 2024 Feb 12. doi: 10.2169/internalmedicine.3259-23. Online ahead of print. Intern Med. 2024. PMID: 38346734 Free article.
SGLT2I improves the pathological condition of NAFLD/NASH in T2DM patients. However, cases of rebound during long-term SGLT2I treatment have been reported. This study investigated the efficacy of SGLT2I and GLP-1A combination therapy in diabetic patients with NAFLD by exami …
SGLT2I improves the pathological condition of NAFLD/NASH in T2DM patients. However, cases of rebound during long-term SGLT2I treatmen …
Short- and long-term outcomes of endoscopic submucosal dissection and laparoscopic and endoscopic cooperative surgery for superficial non-ampullary duodenal epithelial tumors.
Seya M, Dohi O, Iwai N, Ochiai T, Mukai H, Yamauchi K, Fukui H, Miyazaki H, Yasuda T, Ishida T, Doi T, Hirose R, Inoue K, Harusato A, Yoshida N, Uchiyama K, Ishikawa T, Takagi T, Morinaga Y, Kubota T, Konishi H, Itoh Y. Seya M, et al. Among authors: ishikawa t. Surg Endosc. 2024 Apr;38(4):1784-1790. doi: 10.1007/s00464-023-10666-x. Epub 2024 Jan 29. Surg Endosc. 2024. PMID: 38286838
BACKGROUND AND AIMS: This retrospective study aimed to compare the short- and long-term outcomes of endoscopic submucosal dissection and laparoscopic and endoscopic cooperative surgery in patients with superficial non-ampullary duodenal epithelial tumors. ...CONCLUSION: ES …
BACKGROUND AND AIMS: This retrospective study aimed to compare the short- and long-term outcomes of endoscopic submucosal dissection …
Risk factors for death from other diseases after curative gastrectomy and lymph node dissection for gastric cancer.
Hanyu T, Ichikawa H, Kano Y, Ishikawa T, Muneoka Y, Hirose Y, Miura K, Tajima Y, Shimada Y, Sakata J, Wakai T. Hanyu T, et al. Among authors: ishikawa t. BMC Surg. 2024 Jan 8;24(1):16. doi: 10.1186/s12893-024-02313-6. BMC Surg. 2024. PMID: 38191419 Free PMC article.
Paying attention to comorbidities, minimizing the choice of total gastrectomy and avoiding postoperative complications are essential to maintain the long-term prognosis after gastrectomy....
Paying attention to comorbidities, minimizing the choice of total gastrectomy and avoiding postoperative complications are essential to main …
Study Profile of the Tsuruoka Metabolomics Cohort Study (TMCS).
Harada S, Iida M, Miyagawa N, Hirata A, Kuwabara K, Matsumoto M, Okamura T, Edagawa S, Kawada Y, Miyake A, Toki R, Akiyama M, Kawai A, Sugiyama D, Sato Y, Takemura R, Fukai K, Ishibashi Y, Kato S, Kurihara A, Sata M, Shibuki T, Takeuchi A, Kohsaka S, Sawano M, Shoji S, Izawa Y, Katsumata M, Oki K, Takahashi S, Takizawa T, Maruya H, Nishiwaki Y, Kawasaki R, Hirayama A, Ishikawa T, Saito R, Sato A, Soga T, Sugimoto M, Tomita M, Komaki S, Ohmomo H, Ono K, Otsuka-Yamasaki Y, Shimizu A, Sutoh Y, Hozawa A, Kinoshita K, Koshiba S, Kumada K, Ogishima S, Sakurai-Yageta M, Tamiya G, Takebayashi T. Harada S, et al. Among authors: ishikawa t. J Epidemiol. 2024 Jan 6. doi: 10.2188/jea.JE20230192. Online ahead of print. J Epidemiol. 2024. PMID: 38191178 Free article.
This study is notable for its robust design, high participation rate (89%), and long-term repeated surveys. Moreover, it contributes to precision prevention in Japan and East Asia as a well-established multi-omics platform....
This study is notable for its robust design, high participation rate (89%), and long-term repeated surveys. Moreover, it contributes …
354 results